CD8A and melanoma: We have previously shown that LVD in the TME of human melanoma positively correlates with tumor infiltrating CD8+ T cells [5] and recent findings in a melanoma mouse model and a clinical immunotherapy trial demonstrated that the presence of LECs increased the likelihood of immunotherapy success through their support of T cell responses [22].